Endomyocardial Biopsy Market Size, Growth, Report 2023-2032
The global endomyocardial biopsy market surpassed USD 321.57 million in 2022 and is expected to reach around USD 624.35 million by 2032, growing at a CAGR of 6.86% from 2023 to 2032.
Key Pointers
Report Scope of the Endomyocardial Biopsy Market
| Report Coverage | Details |
| Revenue Share of North America in 2022 | 44.53% |
| Revenue Forecast by 2032 | USD 624.35 million |
| Growth Rate from 2023 to 2032 | CAGR of 6.86% |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
| Companies Covered | Argon Medica Devices, Inc.; Cordis; Mermaid Medical; Terum Corporation; Scholten Surgical Instruments, Inc.; Changzhou Lookmed Medical Instrument Co., Ltd.; Fehling Instruments |
The growth of the market is attributed to factors such as increasing prevalence of Cardiovascular Disorders (CVDs), rising demand for minimally invasive surgical procedures, and favorable reimbursement policies for coronary intervention procedures.
Increase in technological advancements and investment of multinational companies in the emerging economies serve as ideal opportunities for the growth and expansion of a market. There is a trend of healthcare reforms and advancements in technology for medical products and devices in the emerging economies. This creates an opportunity for manufacturers to introduce their products and capture a significant portion of the market. Countries like India, China and others are developing and are bringing about incremental changes to their healthcare systems providing enhanced treatment options to patients.
Furthermore, the availability of well-established healthcare infrastructure in developed countries enables easy accessibility to advanced diagnostic and treatment options. According to data published by the United Network for Organ Sharing, in 2022, over 4,111 heart transplants were performed in the U.S. As the number of heart transplants increases, the need for regular monitoring and early detection of rejection would also increase. This would further boost the demand for endomyocardial biopsy procedures.
The pandemic has highlighted the importance of regular monitoring and early detection of heart conditions among people which would further drive demand for the endomyocardial biopsy procedure in the coming years. Additionally, the adoption of remote monitoring technologies is expected to make endomyocardial biopsy procedures more accessible to patients, further supporting the growth of the market.
Product Insights
Based on product, the forceps segment accounted for the largest market share of 71.7% in 2022. Forceps are commonly used to perform Endomyocardial Biopsy (EMB) procedures. The development of new and improved forceps with better grip and precision is driving the demand for forceps in EMB procedures. Moreover, forceps are now available in a range of sizes and shapes to suit the needs of different patients and procedures. Companies such as Argon Medical Devices, Inc., Cordis, among others offer a range of forceps which could be used during the biopsy procedures.
The accessories segment is anticipated to register lucrative growth during the forecast period. Several other accessories that are commonly used in EMB procedures are guidewires, biopsy needles, curve tips, and catheters. The choice of an accessory depends on the specific needs of the procedure and the patient's analysis. Furthermore, advancements in EMB accessories, such as flexible needles, and improved imaging tools, have also contributed to the market growth.
Tip Insights
The straight tip segment dominated the market in 2022 and accounted for the largest share of 36.76% of the global revenue. The straight tip is designed to allow precision and accuracy during the procedure. The use of a straight tip minimizes the risk of tissue damage during the biopsy, ensuring that the collected tissue is suitable for accurate diagnosis. The straight tip is commonly used for initial puncture and navigation through the heart, allowing for the collection of a tissue sample. Thus, these factors are expected to further drive the segment growth.
Furthermore, the pre-curved segment is expected to expand at a substantial CAGR during the forecast period. The pre-curved tip provides flexibility during the procedure, reducing the risk of damage to surrounding tissues. These factors are expected to further boost the adoption of pre-curved tips during the forecast period.
End-use Insights
In 2022, the hospital segment accounted for the largest market share at 50.48%. Factors such as increasing number of transplants, would further increase the volume of procedures performed in the hospitals, thereby generating additional revenue from diagnostic tests and follow-up care which would further improve the patient outcomes. Furthermore, the rising number of hospitals globally is expected to fuel market growth, as more people will have access to healthcare services.
The Ambulatory Surgery Center (ASC) is anticipated to exhibit a significant CAGR of 6.02% during the forecast period. ASCs are majorly preferred by the patients who prefer a more convenient and cost-effective alternative to hospital-based procedures. In addition, with the continuous advancements in technology, EMB procedures can now be safely and effectively performed in an ASC setting, reducing the need for hospitalization.
Regional Insights
The North American region held the largest share of 44.53% in 2022. The region has a well-established healthcare infrastructure and a large patient pool with a high prevalence of cardiovascular diseases, which makes it an attractive market for EMB procedures. In addition, the presence of key market players is also contributing to the growth of the market by investing in R&D, introducing innovative products, and providing advanced training and education to healthcare providers.
Asia Pacific is projected to witness the fastest growth during the forecast period. The growth of the market is attributed to factors such as increasing awareness about heart diseases and the need for early diagnosis & treatment. Furthermore, improving healthcare infrastructure in the region has boosted the availability of endomyocardial biopsy services.
Endomyocardial Biopsy Market Segmentations:
By Product
By Tip
By End-use
By Regional
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Product Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Endomyocardial Biopsy Market
5.1. COVID-19 Landscape: Endomyocardial Biopsy Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Endomyocardial Biopsy Market, By Product
8.1. Endomyocardial Biopsy Market, by Product, 2023-2032
8.1.1 Forceps
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Accessories
8.1.2.1. Market Revenue and Forecast (2020-2032)
Chapter 9. Global Endomyocardial Biopsy Market, By Tip
9.1. Endomyocardial Biopsy Market, by Tip, 2023-2032
9.1.1. Maxi-curved
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Straight
9.1.2.1. Market Revenue and Forecast (2020-2032)
9.1.3. Pre-curved
9.1.3.1. Market Revenue and Forecast (2020-2032)
9.1.4. Others
9.1.4.1. Market Revenue and Forecast (2020-2032)
Chapter 10. Global Endomyocardial Biopsy Market, By End-use
10.1. Endomyocardial Biopsy Market, by End-use, 2023-2032
10.1.1. Hospitals
10.1.1.1. Market Revenue and Forecast (2020-2032)
10.1.2. Ambulatory Surgical Centers
10.1.2.1. Market Revenue and Forecast (2020-2032)
10.1.3. Others
10.1.3.1. Market Revenue and Forecast (2020-2032)
Chapter 11. Global Endomyocardial Biopsy Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Product (2020-2032)
11.1.2. Market Revenue and Forecast, by Tip (2020-2032)
11.1.3. Market Revenue and Forecast, by End-use (2020-2032)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Product (2020-2032)
11.1.4.2. Market Revenue and Forecast, by Tip (2020-2032)
11.1.4.3. Market Revenue and Forecast, by End-use (2020-2032)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Product (2020-2032)
11.1.5.2. Market Revenue and Forecast, by Tip (2020-2032)
11.1.5.3. Market Revenue and Forecast, by End-use (2020-2032)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product (2020-2032)
11.2.2. Market Revenue and Forecast, by Tip (2020-2032)
11.2.3. Market Revenue and Forecast, by End-use (2020-2032)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Product (2020-2032)
11.2.4.2. Market Revenue and Forecast, by Tip (2020-2032)
11.2.4.3. Market Revenue and Forecast, by End-use (2020-2032)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Product (2020-2032)
11.2.5.2. Market Revenue and Forecast, by Tip (2020-2032)
11.2.5.3. Market Revenue and Forecast, by End-use (2020-2032)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Product (2020-2032)
11.2.6.2. Market Revenue and Forecast, by Tip (2020-2032)
11.2.6.3. Market Revenue and Forecast, by End-use (2020-2032)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Product (2020-2032)
11.2.7.2. Market Revenue and Forecast, by Tip (2020-2032)
11.2.7.3. Market Revenue and Forecast, by End-use (2020-2032)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product (2020-2032)
11.3.2. Market Revenue and Forecast, by Tip (2020-2032)
11.3.3. Market Revenue and Forecast, by End-use (2020-2032)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Product (2020-2032)
11.3.4.2. Market Revenue and Forecast, by Tip (2020-2032)
11.3.4.3. Market Revenue and Forecast, by End-use (2020-2032)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Product (2020-2032)
11.3.5.2. Market Revenue and Forecast, by Tip (2020-2032)
11.3.5.3. Market Revenue and Forecast, by End-use (2020-2032)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Product (2020-2032)
11.3.6.2. Market Revenue and Forecast, by Tip (2020-2032)
11.3.6.3. Market Revenue and Forecast, by End-use (2020-2032)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Product (2020-2032)
11.3.7.2. Market Revenue and Forecast, by Tip (2020-2032)
11.3.7.3. Market Revenue and Forecast, by End-use (2020-2032)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product (2020-2032)
11.4.2. Market Revenue and Forecast, by Tip (2020-2032)
11.4.3. Market Revenue and Forecast, by End-use (2020-2032)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Product (2020-2032)
11.4.4.2. Market Revenue and Forecast, by Tip (2020-2032)
11.4.4.3. Market Revenue and Forecast, by End-use (2020-2032)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Product (2020-2032)
11.4.5.2. Market Revenue and Forecast, by Tip (2020-2032)
11.4.5.3. Market Revenue and Forecast, by End-use (2020-2032)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Product (2020-2032)
11.4.6.2. Market Revenue and Forecast, by Tip (2020-2032)
11.4.6.3. Market Revenue and Forecast, by End-use (2020-2032)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Product (2020-2032)
11.4.7.2. Market Revenue and Forecast, by Tip (2020-2032)
11.4.7.3. Market Revenue and Forecast, by End-use (2020-2032)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product (2020-2032)
11.5.2. Market Revenue and Forecast, by Tip (2020-2032)
11.5.3. Market Revenue and Forecast, by End-use (2020-2032)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Product (2020-2032)
11.5.4.2. Market Revenue and Forecast, by Tip (2020-2032)
11.5.4.3. Market Revenue and Forecast, by End-use (2020-2032)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Product (2020-2032)
11.5.5.2. Market Revenue and Forecast, by Tip (2020-2032)
11.5.5.3. Market Revenue and Forecast, by End-use (2020-2032)
Chapter 12. Company Profiles
12.1. Argon Medica Devices, Inc.
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Cordis
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Mermaid Medical
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Terum Corporation
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Scholten Surgical Instruments, Inc.
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Changzhou Lookmed Medical Instrument Co., Ltd.
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Fehling Instruments
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers